Thermoresponsive curcumin/DsiRNA nanoparticle gels for the treatment of diabetic wounds: synthesis and drug release

References

• 1 Lipsky BA. Evidence-based antibiotic therapy of diabetic foot infections. FEMS Immunol. Med. Microbiol. 26(3–4), 267–276 (1999).
  Medline CASGoogle Scholar
• 2 Pecoraro RE, Reiber GE. Pathways to diabetic limb amputation: basis for prevention. Diabetes Care. 13(5), 513–521 (1990).
  Medline CASGoogle Scholar
• 3 Falanga V. Wound healing and its impairment in the diabetic foot. The Lancet 366(9498), 1736–1743 (2005).
  MedlineGoogle Scholar
• 4 Galiano RD, Tepper OM, Pelo CR et al. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am. J. Pathol. 164(6), 1935–1947 (2004).
  Medline CASGoogle Scholar
• 5 Galkowska H, Wojewodzka U, Olszewski WL. Chemokines, cytokines, and growth factors in keratinocytes and dermal endothelial cells in the margin of chronic diabetic foot ulcers. Wound Repair Regen. 14(5), 558–565 (2006).
  MedlineGoogle Scholar
• 6 Gibran NS, Jang Y-C, Isik FF et al. Diminished neuropeptide levels contribute to the impaired cutaneous healing response associated with diabetes mellitus. J. Surg. Res. 108(1), 122–128 (2002).
  Medline CASGoogle Scholar
• 7 Goren I, Müller E, Pfeilschifter J et al. Severely impaired insulin signaling in chronic wounds of diabetic Ob/Ob mice: a potential role of tumor necrosis factor-A. Am. J. Pathol. 168(3), 765–777 (2006).
  Medline CASGoogle Scholar
• 8 Lobmann R, Ambrosch A, Schultz G et al. Expression of matrix-metalloproteinases and their inhibitors in the wounds of diabetic and non-diabetic patients. Diabetologia 45(7), 1011–1016 (2002).
  Medline CASGoogle Scholar
• 9 Maruyama K, Asai J, Ii M et al. Decreased macrophage number and activation lead to reduced lymphatic vessel formation and contribute to impaired diabetic wound healing. Am. J. Pathol. 170(4), 1178–1191 (2007).
  MedlineGoogle Scholar
• 10 Guo SA, Dipietro LA. Factors affecting wound healing. J. Dent. Res. 89(3), 219–229 (2010).
  Medline CASGoogle Scholar
• 11 Kolluru GK, Bir SC, Kevil CG. Endothelial dysfunction and diabetes: effects on angiogenesis, vascular remodeling, and wound healing. Int. J. Vasc. Med. 2012, 1–30 (2012).
  Google Scholar
• 12 Lipsky BA, Berendt AR, Cornia PB et al. Infectious diseases society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections. Clin. Infect. Dis. 54(2012), e132–e173.
  MedlineGoogle Scholar
• 13 Dewick PM. Medicinal Natural Products: A Biosynthetic Approach (Second Ed.). John Wiley & Sons, London, UK (2002).
  Google Scholar
• 14 Aggarwal BB, Kumar A, Bharti AC. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23(1A), 363–398 (2003).
  Medline CASGoogle Scholar
• 15 Sharma R, Gescher A, Steward W. Curcumin: the story so far. Eur. J. Cancer 41(13), 1955–1968 (2005).
  Medline CASGoogle Scholar
• 16 Shishodia S, Sethi G, Aggarwal BB. Curcumin: getting back to the roots. Ann. NY Acad. Sci. 1056, 206–217 (2005).
  Medline CASGoogle Scholar
• 17 Prausnitz MR, Langer R. Transdermal drug delivery. Nat. Biotechnol. 26(11), 1261–1268 (2008).
  Medline CASGoogle Scholar
• 18 Zhang Z, Tsai PC, Ramezanli T, Michniak-Kohn BB. Polymeric nanoparticles-based topical delivery systems for the treatment of dermatological diseases. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 5(3), 205–218 (2013).
  Medline CASGoogle Scholar
• 19 Raja MAG, Katas H, Hamid ZA, Razali NA. Physicochemical properties and in vitro cytotoxicity studies of chitosan as a potential carrier for dicer-substrate siRNA. J. Nanomater. 2013, 1–10 (2013).
  Google Scholar
• 20 Kim S-K, Rajapakse N. Enzymatic production and biological activities of chitosan oligosaccharides (COS): a review. Carbohydr. Polym. 62(4), 357–368 (2005).
  CASGoogle Scholar
• 21 Kim D-H, Behlke MA, Rose SD, Chang M-S, Choi S, Rossi JJ. Synthetic DsiRNA dicer substrates enhance RNAi potency and efficacy. Nat. Biotechnol. 23(2), 222–226 (2005).
  Medline CASGoogle Scholar
• 22 Yeon S, Chul J, Moo Y. Poly(ethylene oxide)-poly(ethylene oxide)/ply(∈-caprolactone) (PCL) amphiphilic block copolymeric nanospheres: thermo-responsive drug release behaviors. J. Control. Rel. 65(3), 345–358 (2000).
  MedlineGoogle Scholar
• 23 Jørgensen EB, Hvidt S, Brown W, Schillen K. Effects of salts on the micellization and gelation of a triblock copolymer studied by rheology and light scattering. Macromolecules 30(8), 2355–2364 (1997).
  CASGoogle Scholar
• 24 Escobar-Chávez J, López-Cervantes M, Naik A, Kalia Y, Quintanar-Guerrero D, Ganem-Quintanar A. Applications of thermo-reversible pluronic F-127 gels in pharmaceutical formulations. J. Pharm. Pharm. Sci. 9(3), 339–358 (2006).
  Medline CASGoogle Scholar
• 25 Chuah LH, Billa N, Roberts CJ, Burley JC, Manickam S. Curcumin-containing chitosan nanoparticles as a potential mucoadhesive delivery system to the colon. Pharm. Dev. Technol. 18(3), 591–599 (2013).
  Medline CASGoogle Scholar
• 26 Liu L, Zhou C, Xia X, Liu Y. Self-assembled lecithin/chitosan nanoparticles for oral insulin delivery: preparation and functional evaluation. Int. J. Nanomedicine 11, 761–769 (2016).
  Medline CASGoogle Scholar
• 27 Mohanraj V, Chen Y. Nanoparticles: a review. Trop. J. Pharm. Res. 5(1), 561–573 (2007).
  Google Scholar
• 28 Gan Q, Wang T, Cochrane C, Mccarron P. Modulation of surface charge, particle size and morphological properties of chitosan–TPP nanoparticles intended for gene delivery. Colloids Surf. B. Biointerfaces. 44(2–3), 65–73 (2005).
  Medline CASGoogle Scholar
• 29 Shu X, Zhu K. The influence of multivalent phosphate structure on the properties of ionically cross-linked chitosan films for controlled drug release. Eur. J. Pharm. Biopharm. 54(2), 235–243 (2002).
  Medline CASGoogle Scholar
• 30 Chen Y, Mohanraj VJ, Parkin JE. Chitosan-dextran sulfate nanoparticles for delivery of an anti-angiogenesis, Peptide. Lett. Pept. Sci. 10(5), 621–629 (2003).
  CASGoogle Scholar
• 31 Gan Q, Wang T. Chitosan nanoparticle as protein delivery carrier – systematic examination of fabrication conditions for efficient loading and release. Colloids Surf. B. Biointerfaces 59(1), 24–34 (2007).
  Medline CASGoogle Scholar
• 32 Couvreur P, Barratt G, Fattal E, Legrand P, Vauthier C. Nanocapsule technology: a review. Crit. Rev. Ther. Drug Carrier Syst. 19(2), 99–134 (2002).
  Medline CASGoogle Scholar
• 33 Modaresi SMS, Ejtemaei Mehr S, Faramarzi MA, Esmaeilzadeh Gharehdaghi E, Azarnia M, Modarressi MH et al. Preparation and characterization of self-assembled chitosan nanoparticles for the sustained delivery of streptokinase: an in vivo study. Pharm. Dev. Technol. 19(5), 593–597 (2014).
  Medline CASGoogle Scholar
• 34 Li X, Deng X, Yuan M, Xiong C, Huang Z, Zhang Y et al. Investigation on process parameters involved in preparation of poly-DL-lactide-poly (ethylene glycol) microspheres containing Leptospira interrogans antigens. Int. J. Pharm. 178(2), 245–255 (1999).
  Medline CASGoogle Scholar
• 35 Mehta RC, Thanoo B, Deluca PP. Peptide containing microspheres from low molecular weight and hydrophilic poly (D, L-lactide-co-glycolide). J. Control. Rel. 41, 249–257 (1996).
  CASGoogle Scholar
• 36 Rafati H, Coombes A, Adler J, Holland J, Davis S. Protein-loaded poly (DL-lactide-co-glycolide) microparticles for oral administration: formulation, structural and release characteristics. J. Control. Rel. 43(1), 89–102 (1997).
  CASGoogle Scholar
• 37 Maurya SD, Aggarwal S, Kumar G, Tilak VK. Design and evaluation of SRM microspheres of metformin hydrochloride. Pharmacie Globale. 1(6), 1–5 (2010).
  Google Scholar
• 38 Gref R, Domb A, Quellec P et al. The controlled intravenous delivery of drugs using peg-coated sterically stabilized nanospheres. Adv. Drug Deliv. Rev. 64, 316–326 (2012).
  Google Scholar
• 39 Katas H, Alpar HO. Development and characterisation of chitosan nanoparticles for siRNA delivery. J. Control. Release 115(2), 216–225 (2006).
  Medline CASGoogle Scholar
• 40 Hasanovic A, Zehl M, Reznicek G, Valenta C. Chitosan tripolyphosphate nanoparticles as a possible skin drug delivery system for aciclovir with enhanced stability. J. Pharm. Pharmacol. 61(12), 1609–1616 (2009).
  Medline CASGoogle Scholar
• 41 Holzerny P, Ajdini B, Heusermann W et al. Biophysical properties of chitosan/siRNA polyplexes: profiling the polymer/siRNA interactions and bioactivity. J. Control. Release 157(2), 297–304 (2012).
  Medline CASGoogle Scholar
• 42 Csaba N, Köping-Höggård M, Alonso MJ. Ionically crosslinked chitosan/tripolyphosphate nanoparticles for oligonucleotide and plasmid DNA delivery. Int. J. Pharm. 382(1–2), 205–214 (2009).
  Medline CASGoogle Scholar
• 43 Martin ME, Rice KG. Peptide-guided gene delivery. AAPS J. 9(1), E18–E29 (2007).
  Medline CASGoogle Scholar
• 44 Baloglu E, Karavana SY, Senyigit ZA, Guneri T. Rheological and mechanical properties of poloxamer mixtures as a mucoadhesive gel base. Pharm. Dev. Technol. 16(6), 627–636 (2011).
  Medline CASGoogle Scholar
• 45 Cabana A, Aıt-Kadi A, Juhász J. Study of the gelation process of polyethylene oxide a-polypropylene oxide b-polyethylene oxide a copolymer (poloxamer 407) aqueous solutions. J. Colloid Interface Sci. 190(2), 307–312 (1997).
  Medline CASGoogle Scholar
• 46 Jain NJ, Aswal V, Goyal P, Bahadur P. Micellar structure of an ethylene oxide-propylene oxide block copolymer: a small-angle neutron scattering study. J. Phys. Chem. B 102(43), 8452–8458 (1998).
  CASGoogle Scholar
• 47 Bentley MVL, Marchetti JM, Ricardo N, Ali-Abi Z, Collett JH. Influence of lecithin on some physical chemical properties of poloxamer gels: rheological, microscopic and in vitro permeation studies. Int. J. Pharm. 193(1), 49–55 (1999).
  Medline CASGoogle Scholar
• 48 Galgatte UC, Chaudhari PD. Preformulation study of poloxamer 407 gels: effect of additives. J. Pharm. Pharm. Sci. 6(1), 130–133 (2014).
  Google Scholar
• 49 Li XY, Zhu ZJ, Cheng AY. Characteristics of poloxamer thermosensitive in situ gel of dexamethasone sodium phosphate. Yao Xue Xue Bao 43(2), 208–213 (2008).
  Medline CASGoogle Scholar
• 50 Kim E-Y, Gao Z-G, Park J-S, Li H, Han K. rhEGF/HP-β-CD complex in poloxamer gel for ophthalmic delivery. Int. J. Pharm. 233(1–2), 159–167 (2002).
  Medline CASGoogle Scholar
• 51 Ryu J-M, Chung S-J, Lee M-H, Kim C-K, Shim C-K. Increased bioavailability of propranolol in rats by retaining thermally gelling liquid suppositories in the rectum. J. Control. Rel. 59(2), 163–172 (1999).
  Medline CASGoogle Scholar
• 52 Miller SC, Drabik BR. Rheological properties of poloxamer vehicles. Int. J. Pharm. 18(3), 269–276 (1984).
  CASGoogle Scholar
• 53 Gong C, Qi T, Wei X et al. Thermosensitive polymeric hydrogels as drug delivery systems. Curr. Med. Chem. 20(1), 79–94 (2013).
  Medline CASGoogle Scholar
• 54 Meenakshi P, Hetal T, Kasture P. Preparation and evaluation of thermoreversible formulations of flunarizine hydrochloride for nasal delivery. Int. J. Pharm. Pharm. Sci. 2(4), 115–120 (2010).
  Google Scholar
• 55 Choi H-G, Jung J-H, Ryu J-M, Yoon S-J, Oh Y-K, Kim C-K. Development of in situ-gelling and mucoadhesive acetaminophen liquid suppository. Int. J. Pharm. 165(1), 33–44 (1998).
  CASGoogle Scholar
• 56 Edsman K, Carlfors J, Petersson R. Rheological evaluation of poloxamer as an in situ gel for ophthalmic use. Eur. J. Pharm. Sci. 6(2), 105–112 (1998).
  Medline CASGoogle Scholar
• 57 Kar F, Arslan N. Effect of temperature and concentration on viscosity of orange peel pectin solutions and intrinsic viscosity–molecular weight relationship. Carbohydr. Polym. 40(4), 277–284 (1999).
  CASGoogle Scholar
• 58 Wu T, Zivanovic S, Draughon FA, Conway WS, Sams CE. Physicochemical properties and bioactivity of fungal chitin and chitosan. J. Agric. Food Chem. 53(10), 3888–3894 (2005).
  Medline CASGoogle Scholar
• 59 Jia-Hui Y, Yu-Min D, Hua Z. Blend films of chitosan–gelatin. Wuhan Univ. J. Nat. Sci. 4(4), 476–476 (1999).
  Google Scholar
• 60 Mohanty C, Sahoo SK. The in vitro stability and in vivo pharmacokinetics of curcumin prepared as an aqueous nanoparticulate formulation. Biomaterials 31(25), 6597–6611 (2010).
  Medline CASGoogle Scholar
• 61 Zhang W, Shi Y, Chen Y, Hao J, Sha X, Fang X. The potential of pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice models. Biomaterials 32(25), 5934–5944 (2011).
  Medline CASGoogle Scholar
• 62 Gilbert JC, Hadgraft J, Bye A, Brookes LG. Drug release from Pluronic F-127 gels. Int. J. Pharm. 32(2–3), 223–228 (1986).
  CASGoogle Scholar
• 63 Ibrahim E-S, Ismail S, Fetih G, Shaaban O, Hassanein K, Abdellah N. Development and characterization of thermosensitive pluronic-based metronidazole in situ gelling formulations for vaginal application. Acta Pharm. 62(1), 59–70 (2012).
  Medline CASGoogle Scholar
• 64 Brodin B, Steffansen B, Nielsen CU. Passive diffusion of drug substances: the concepts of flux and permeability. In: Molecular Biopharmaceutics: aspects of Drug Characterisation, Drug Delivery and Dosage Form Evaluation. Steffeansen B, Brodin B, Nielson CU (Eds). Pharmaceutical Press, London, UK, 135–151 (2010).
  Google Scholar